Aspira Women’s Health (AWH) Scheduled to Post Earnings on Wednesday

Aspira Women’s Health (NASDAQ:AWHGet Rating) is scheduled to be announcing its earnings results before the market opens on Wednesday, May 11th. Analysts expect the company to announce earnings of ($0.08) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Aspira Women’s Health (NASDAQ:AWHGet Rating) last issued its earnings results on Wednesday, March 23rd. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.01. Aspira Women’s Health had a negative net margin of 464.80% and a negative return on equity of 75.46%. The firm had revenue of $1.85 million for the quarter, compared to analysts’ expectations of $1.90 million. During the same quarter last year, the business earned ($0.58) earnings per share. On average, analysts expect Aspira Women’s Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Shares of Aspira Women’s Health stock opened at $0.65 on Wednesday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 5.08 and a current ratio of 5.10. Aspira Women’s Health has a 52-week low of $0.63 and a 52-week high of $6.25. The stock has a market capitalization of $73.12 million, a price-to-earnings ratio of -2.33 and a beta of 2.88. The company’s 50 day moving average price is $0.97 and its 200-day moving average price is $1.58.

Several brokerages have recently issued reports on AWH. Cantor Fitzgerald restated an “overweight” rating on shares of Aspira Women’s Health in a report on Tuesday, January 11th. Zacks Investment Research upgraded shares of Aspira Women’s Health from a “sell” rating to a “hold” rating in a report on Monday, March 14th.

A number of hedge funds have recently made changes to their positions in AWH. Virtu Financial LLC purchased a new stake in Aspira Women’s Health in the fourth quarter worth $28,000. Citigroup Inc. lifted its position in Aspira Women’s Health by 109.8% during the fourth quarter. Citigroup Inc. now owns 19,323 shares of the company’s stock valued at $34,000 after buying an additional 10,112 shares during the period. Walleye Trading LLC purchased a new position in Aspira Women’s Health during the fourth quarter valued at $42,000. Royal Bank of Canada lifted its position in Aspira Women’s Health by 57.3% during the second quarter. Royal Bank of Canada now owns 9,347 shares of the company’s stock valued at $53,000 after buying an additional 3,403 shares during the period. Finally, Wells Fargo & Company MN lifted its position in Aspira Women’s Health by 416.6% during the fourth quarter. Wells Fargo & Company MN now owns 51,658 shares of the company’s stock valued at $92,000 after buying an additional 41,658 shares during the period. 54.01% of the stock is owned by institutional investors.

About Aspira Women’s Health (Get Rating)

Aspira Women's Health Inc, together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer.

Further Reading

Earnings History for Aspira Women's Health (NASDAQ:AWH)

Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with's FREE daily email newsletter.